Miral, Mary Joy H.
HRN: 11-40-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2022
CEFUROXIME 500MG (TAB)
06/21/2022
06/28/2022
PO
500mg
BID X 7 Days
S/P Episiorraphy; Thickly Meconium Stained Amniotic Fluid
Waiting Final Action
Indication: Empirical De-escalation Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes